Contraindicated Use of Bevacizumab and Toxicity in Elderly Patients With Cancer

PURPOSE: Drugs are approved on the basis of randomized trials conducted in selected populations. However, once approved, these treatments are usually expanded to patients ineligible for the trial. PATIENTS AND METHODS: We used the SEER-Medicare database to identify subjects older than 65 years with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hershman, Dawn L., Wright, Jason D., Lim, Emerson, Buono, Donna L., Tsai, Wei Yann, Neugut, Alfred I.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Clinical Oncology 2013
Schlagworte:
Original Reports
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3782151/
https://ncbi.nlm.nih.gov/pubmed/24002522
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.48.4857
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge